Intervacc is trading 3.08% up at €0.08, with the move appearing primarily driven by broader biotechnology-sector strength.

  • XBI was up 2.75% during the regular session.
  • No clear company-specific announcement directly explaining the move was identified for September 3, 2026.
  • The latest company-related item was a DNB Carnegie Micro Cap Day flash comment published September 1 and updated September 2; its contents do not establish causation. The move therefore appears unrelated to a confirmed Intervacc catalyst.